Sponsor:
Criterium, Inc.
Code:
NCT05458674
Conditions
Breast Cancer
Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tucatinib
Eribulin
Trastuzumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations